TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Immuno-oncology Clinical Trials Market Projected to Reach USD 23.63 Billion by 2032 at a CAGR of 12.37% - SNS Insider

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Sns Insider
Immuno-oncology Clinical Trials Market Projected to Reach USD 23.63 Billion by 2032 at a CAGR of 12.37% - SNS Insider

The global immuno-oncology clinical trials market is expected to grow from USD 8.30 billion in 2023 to USD 23.63 billion by 2032, driven by rising cancer incidence, significant R&D investments, and advancements in immunotherapies like checkpoint inhibitors and CAR-T cell therapies.

Insights
MRK   positive

Actively exploring strategic acquisitions like SpringWorks Therapeutics to strengthen oncology medicine pipeline